The latest decision by the Federal Reserve to hold rates steady is not doing any favors to the stock market overall. The decision to do nothing is stoking fears of a recession, sending broad market indices lower in the process.
The S&P 500, Dow Jones Industrial Average (Dow), and Nasdaq Composite are all stock market indexes used to measure the performance of various aspects of the U.S. stock market.
Dow Jones biotech giant Amgen, along with MercadoLibre, Ferrari and Lennar, are in or near buy zones in today's stock market sell-off.
Merck fell as it cut its guidance and performance from its HPV drug disappointed. Microsoft delivered a solid earnings report, but it wasn't good enough for the market.
Amazon uses the cash flow from its e-commerce business to help expand into other industries. Amazon Web Services is building out its platform to assist companies with building their own AI models and applications.
The Dow stocks have finally had a chance to out-flex the outperforming, tech-heavy Nasdaq 100 for a change. With value plays, mid-caps, and “boring” blue chips starting to gain steam over their high-flying tech counterparts, the market rally's breadth stands to improve.
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Wednesday.
The third quarter of 2024 is shaping up to be a very interesting time. Wall Street is largely anticipating that the Federal Reserve will cut interest rates in September.
The Dow Jones Industrial Average is a laggard in 2024. While other indices roared higher over the first half of the year, the venerable Dow gained only about half of its peers.
U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Tuesday.
U.S. stocks were mostly higher toward the end of trading, while the Dow Jones index traded slightly lower on Monday.
Visa's earnings were somewhat disappointing. Growth is slowing in key markets.